Lytix Biopharma AS (LYTIX) — Financial Flexibility Index
Lytix Biopharma AS (LYTIX) has a Financial Flexibility Index of -3.03x as of December 2025. Free cash flow of Nkr-59.85 Million (operating CF Nkr-59.85 Million minus capex Nkr0.00) represents -3% of total liabilities (Nkr19.77 Million). Also explore LYTIX net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lytix Biopharma AS Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Lytix Biopharma AS across 9 annual periods. Check LYTIX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Lytix Biopharma AS (2017–2025)
Year-by-year free cash flow to debt coverage for Lytix Biopharma AS. For the full company profile including market capitalisation, see Lytix Biopharma AS market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.03x | Nkr-59.85 Million | Nkr-59.85 Million | Nkr19.77 Million | ▼ -66.2% |
| 2024 | -1.82x | Nkr-70.37 Million | Nkr-70.37 Million | Nkr38.64 Million | ▲ +76.2% |
| 2023 | -7.64x | Nkr-95.92 Million | Nkr-95.97 Million | Nkr12.55 Million | ▼ -148.4% |
| 2022 | -3.08x | Nkr-51.95 Million | Nkr-52.10 Million | Nkr16.89 Million | ▲ +8.3% |
| 2021 | -3.35x | Nkr-44.74 Million | Nkr-44.90 Million | Nkr13.34 Million | ▼ -76.5% |
| 2020 | -1.90x | Nkr-24.19 Million | Nkr-24.35 Million | Nkr12.73 Million | ▲ +80.0% |
| 2019 | -9.51x | Nkr-36.67 Million | Nkr-36.82 Million | Nkr3.85 Million | ▼ -133.9% |
| 2018 | -4.07x | Nkr-72.62 Million | Nkr-72.62 Million | Nkr17.85 Million | ▼ -106.1% |
| 2017 | -1.97x | Nkr-69.67 Million | Nkr-69.67 Million | Nkr35.30 Million | — |